Trump Action Archive

A searchable record of documented actions, compiled weekly from public sources.

3 events matching

Export CSVResearcher JSONAnalyst Newest first · Oldest first
Filtering Week: Week 67 × Category: Economic Structure × Attack target: Public Health × Clear all ☆ Save this search
Tier 1 carried by a primary record Corroborated 2+ independent news desks Every result is verified and democracy-related.

Open an event to see its evidence. Attack and trait tags link to their definitions

May 1, 2026 The DEA placed four synthetic cannabinoids into Schedule I Tier 1 · Primary Economic Structure

The rule tightened federal drug controls and expanded criminal and regulatory restrictions in response to public-health risk claims.

Primary sourceA record that carries the claim alone

Supporting reports

  • DEA Schedules Synthetic Cannabinoids as Schedule I Substances — The Drug Enforcement Administration (DEA) has issued a final rule placing four synthetic cannabinoids—4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA—into Schedule I of the Controlled Substances Act.
Attacks
Verified: Tier 1 primary record Week 67 – 2026-04-25–2026-05-01 wk67_ES_035
Apr 30, 2026 The FDA proposed withdrawing approval of TAVNEOS over effectiveness and data-integrity concerns Tier 1 · Primary Economic Structure

The proposal showed a regulator using its authority to revisit a drug approval when evidence and truthfulness in the application were in doubt.

Primary sourceA record that carries the claim alone

Supporting reports

  • FDA Proposes Withdrawal of TAVNEOS Approval — The FDA has proposed withdrawing approval for TAVNEOS (avacopan) capsules, citing lack of substantial evidence of effectiveness and untrue statements in the application.
Verified: Tier 1 primary record Week 67 – 2026-04-25–2026-05-01 wk67_ES_028
Apr 27, 2026 EPA Administrator Lee Zeldin defended EPA deregulation and denied meetings later tied to Bayer evidence Tier 1 · Primary Economic Structure

The hearing highlighted possible agency capture and reduced accountability as environmental regulation was aligned with major corporate interests.

Independently corroborated by4 independent news desks
Supporting reportingSurfacings — do not carry alone

Supporting reports

  • EPA Administrator Lee Zeldin Defends Deregulatory Agenda — EPA Administrator Lee Zeldin faced a contentious House hearing defending the agency's deregulatory agenda, which includes rolling back clean air and water standards and granting exemptions to polluting corporations.
Verified: Tier 1 primary record Week 67 – 2026-04-25–2026-05-01 wk67_ES_005